Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 92 results.
User Information
Export Records
  1. 1.   Creating and screening natural product libraries
  2. Wilson,Brice; Thornburg,Chris; Henrich,Curtis; Grkovic,Tanja; O'Keefe,Barry
  3. Natural product reports. 2020, JUL 1; 37: 893-918.
  1. 2.   Global proteomics and metabolomics in cancer biomarker discovery
  2. Issaq, H. J.; Fox, S. D.; Chan, K. C.; Veenstra, T. D.
  3. Journal of Separation Science. 2011, Dec; 34(24): 3484-3492.
  1. 3.   Femtomole SHAPE Reveals Regulatory Structures in the Authentic XMRV RNA Genome
  2. Grohman, J. K.; Kottegoda, S.; Gorelick, R. J.; Allbritton, N. L.; Weeks, K. M.
  3. Journal of the American Chemical Society. 2011, Dec; 133(50): 20326-20334.
  1. 4.   Proteomic identification of binding targets of isothiocyanates: A perspective on techniques
  2. Mi, L. X.; Xiao, Z.; Veenstra, T. D.; Chung, F. L.
  3. Journal of Proteomics. 2011, Jun; 74(7): 1036-1044.
  1. 5.   Comparison of Fluorescence, Laser-Induced Fluorescence, and Ultraviolet Absorbance Detection for Measuring HPLC Fractionated Protein/Peptide Mixtures
  2. Chan, K. C.; Veenstra, T. D.; Issaq, H. J.
  3. Analytical Chemistry. 2011, Mar; 83(6): 2394-2396.
  1. 6.   KIR genotyping by multiplex PCR-SSP
  2. Kulkarni, S.; Martin, M. P.; Carrington, M.
  3. Methods in molecular biology (Clifton, N.J.). 2010 612: 365-75.
  1. 7.   Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
  2. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J. W.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine-Nanotechnology Biology and Medicine. 2009 5(2): 106-117.
  1. 8.   Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
  2. Issaq, H. J.; Blonder, J.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2009 877(13): 1222-1228.
  1. 9.   Serum and plasma proteomics
  2. Issaq, H. J.; Xiao, Z.; Veenstra, T. D.
  3. Chemical Reviews. 2007, Aug; 107(8): 3601-3620.
  1. 10.   Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers
  2. Meng, Z.; Veenstra, T. D.
  3. Proteomics Clinical Applications. 2007, Aug; 1(8): 747-757.
  1. 11.   Immunological properties of engineered nanomaterials
  2. Dobrovolskaia, M. A.; McNeil, S. E.
  3. Nature Nanotechnology. 2007, Aug; 2(8): 469-478.
  1. 12.   The role of electrophoresis in disease biomarker discovery
  2. Issaq, H. J.; Veenstra, T. D.
  3. Electrophoresis. 2007, Jun; 28(12): 1980-1988.
  1. 13.   Analysis of fullerene-based nanomaterial in serum matrix by CE
  2. Chan, K. C.; Patri, A. K.; Veenstra, T. D.; McNeil, S. E.; Issaq, H. J.
  3. Electrophoresis. 2007, May; 28(10): 1518-1524.
  1. 14.   Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer
  2. Jazii, F. R.; Najafi, Z.; Malekzadeh, R.; Conrads, T. P.; Ziaee, A. A.; Abnet, C.; Yazdznbod, M.; Karkhane, A. A.; Salekdeh, G. H.
  3. World Journal of Gastroenterology. 2006, Nov; 12(44): 7104-7112.
  1. 15.   Proteomic profiling of differentiating osteoblasts
  2. Blonder, J.; Xiao, Z.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2006, Oct; 3(5): 483-496.
  1. 16.   Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells
  2. Lou, J. R.; Fatima, N.; Xiao, Z.; Stauffer, S.; Smythers, G.; Greenwald, P.; Ali, I. U.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, Sep; 15(9): 1598-1606.
  1. 17.   30S ribosomal subunits can be assembled in vivo without primary binding ribosomal protein S15
  2. Bubunenko, M.; Korepanov, A.; Court, D. L.; Jagannathan, I.; Dickinson, D.; Chaudhuri, B. R.; Garber, M. B.; Culver, G. M.
  3. Rna-a Publication of the Rna Society. 2006, Jul; 12(7): 1229-1239.
  1. 18.   Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450
  2. Inami, K.; Nims, R. W.; Srinivasan, A.; Citro, M. L.; Saavedra, J. E.; Cederbaum, A. I.; Keefer, L. K.
  3. Nitric Oxide-Biology and Chemistry. 2006, Jun; 14(4): 309-315.
  1. 19.   A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins
  2. Townsend, D. M.; Findlay, V. J.; Fazilev, F.; Ogle, M.; Fraser, J.; Saavedra, J. E.; Ji, X. H.; Keefer, L. K.; Tew, K. D.
  3. Molecular Pharmacology. 2006, FEB; 69(2): 501-508.
  1. 20.   Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population
  2. Petersen, D. C.; Glashoff, R. H.; Shrestha, S.; Bergeron, J.; Laten, A.; Gold, B.; van Rensburg, E. J.; Dean, M.; Hayes, V. M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 521-526.
  1. 21.   Computational intelligence, bioinformatics and computational biology: A brief overview of methods, problems and perspectives
  2. Kasabov, N.; Sidorov, I. A.; Dimitrov, D. S.
  3. Journal of Computational and Theoretical Nanoscience. 2005, DEC; 2(4): 473-491.
  1. 22.   Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II)
  2. Karaczyn, A. A.; Golebiowski, F.; Kasprzak, K. S.
  3. Chemical Research in Toxicology. 2005, DEC; 18(12): 1934-1942.
  1. 23.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 24.   Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus
  2. Hibbert, C. S.; Rein, A.
  3. Journal of Virology. 2005, JUL; 79(13): 8142-8148.
  1. 25.   Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis
  2. Beltz, H.; Clauss, C.; Piemont, E.; Ficheux, D.; Gorelick, R. J.; Roques, B.; Gabus, C.; Darlix, J. L.; de Rocquigny, H.; Mely, Y.
  3. Journal of Molecular Biology. 2005, MAY 20; 348(5): 1113-1126.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel